Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|September 15, 1986
Growth of human mammary carcinoma cells from biopsy specimens in serum-free medium on extracellular matrixS Biran, I Vlodavsky, Z Fuks, et al.
Oncology|January 1, 1983
The use of carcinoembryonic antigen for identification of human tumor cells in malignant effusionsA T Horowitz, Z Fuks, E Okon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study GroupG Brufman, E Colajori, N Ghilezan, et al.
International Journal of Tissue Reactions|January 1, 1986
Immunofluorescent characterization of fibronectin, laminin, and keratin in normal and neoplastic human mammary epithelial cells in culture and in breast tissue sectionsY Alon, A T Horowitz, S Biran, et al.
Journal of Surgical Oncology|December 1, 1989
Cisplatin, bleomycin, and methotrexate (PBM) chemotherapy in locally advanced and metastatic head and neck cancerB Uziely, T Peretz, A Sulkes, et al.
Immunology Letters|April 1, 1986
In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cellsA J Treves, V Barak, M Halperin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancerA Sulkes, E Gez, M R Pfeffer, et al.
In Vivo (Athens, Greece)|May 1, 1988
The effects of ionizing irradiation on production of thromboxane and prostacyclin by the isolated perfused rat kidneyZ Weshler, A Raz, E Rosenmann, et al.
Journal of Biological Response Modifiers|August 1, 1986
Detection of different interleukin-1 activities in human monocytes and monocytic cell linesV Barak, M Yamin, S Braun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancerM Ben-David, J L Wittliff, M Fekete, et al.
Pageof 9